Biogen Partners with Capsigen on AAV Capsids
By Michelle Liu
Pharma Deals Review: Vol 2021 Issue 6 (Table of Contents)
Published: 17 Jun-2021
DOI: 10.3833/pdr.v2021.i6.2611 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Continuing its push into gene therapies, Biogen has agreed to partner with Capsigen to engineer adeno-associated virus capsids to deliver gene therapies for various CNS and neuromuscular disease targets...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS